Skip to Main Content

Author Details

John P Overington
Institute of Cardiovascular Science, University College London
1988
106
45
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
32929264Artificial intelligence, drug repurposing and peer review.Nat Biotechnol2020
31808676Setting Our Sights on Infectious Diseases.ACS Infect Dis2020
32929264Artificial intelligence, drug repurposing and peer review.Nat Biotechnol2020
33078867PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.Cochrane Database Syst Rev2020
31808676Setting Our Sights on Infectious Diseases.ACS Infect Dis2020
33078867PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.Cochrane Database Syst Rev2020
30476550Meeting the discovery challenge of drug-resistant infections: progress and focusing resources.Drug Discov Today2019
31827124Improving the odds of drug development success through human genomics: modelling study.Sci Rep2019
30476550Meeting the discovery challenge of drug-resistant infections: progress and focusing resources.Drug Discov Today2019
31827124Improving the odds of drug development success through human genomics: modelling study.Sci Rep2019
29276046Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions.Cell Chem Biol2018
29567993Unexplored therapeutic opportunities in the human genome.Nat Rev Drug Discov2018
29472638Unexplored therapeutic opportunities in the human genome.Nat Rev Drug Discov2018
29276046Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions.Cell Chem Biol2018
29472638Unexplored therapeutic opportunities in the human genome.Nat Rev Drug Discov2018
29567993Unexplored therapeutic opportunities in the human genome.Nat Rev Drug Discov2018
27910877A comprehensive map of molecular drug targets.Nat Rev Drug Discov2017
29018348Target Identification of <i>Mycobacterium tuberculosis</i> Phenotypic Hits Using a Concerted Chemogenomic, Biophysical, and Structural Approach.Front Pharmacol2017
28860623Structural and Functional View of Polypharmacology.Sci Rep2017
28678787Classification and analysis of a large collection of in vivo bioassay descriptions.PLoS Comput Biol2017
28453187PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.Cochrane Database Syst Rev2017
28436422Rational design of non-resistant targeted cancer therapies.Sci Rep2017
28356508The druggable genome and support for target identification and validation in drug development.Sci Transl Med2017
29172488Identification of Allosteric Modulators of Metabotropic Glutamate 7 Receptor Using Proteochemometric Modeling.J Chem Inf Model2017
27899562The ChEMBL database in 2017.Nucleic Acids Res2017
27910877A comprehensive map of molecular drug targets.Nat Rev Drug Discov2017
27903890Pharos: Collating protein information to shed light on the druggable genome.Nucleic Acids Res2017
28436422Rational design of non-resistant targeted cancer therapies.Sci Rep2017
28356508The druggable genome and support for target identification and validation in drug development.Sci Transl Med2017
28453187PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.Cochrane Database Syst Rev2017
29172488Identification of Allosteric Modulators of Metabotropic Glutamate 7 Receptor Using Proteochemometric Modeling.J Chem Inf Model2017
29018348Target Identification of <i>Mycobacterium tuberculosis</i> Phenotypic Hits Using a Concerted Chemogenomic, Biophysical, and Structural Approach.Front Pharmacol2017
28678787Classification and analysis of a large collection of in vivo bioassay descriptions.PLoS Comput Biol2017
28860623Structural and Functional View of Polypharmacology.Sci Rep2017
27903890Pharos: Collating protein information to shed light on the druggable genome.Nucleic Acids Res2017
27899562The ChEMBL database in 2017.Nucleic Acids Res2017
27482722Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound-Kinase Activities: A Way toward Selective Promiscuity by Design?J Chem Inf Model2016
27482722Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound-Kinase Activities: A Way toward Selective Promiscuity by Design?J Chem Inf Model2016
26351271Improved large-scale prediction of growth inhibition patterns using the NCI60 cancer cell line panel.Bioinformatics2016
26501955Comprehensive characterization of the Published Kinase Inhibitor Set.Nat Biotechnol2016
26582922SureChEMBL: a large-scale, chemically annotated patent document database.Nucleic Acids Res2016
27800551Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos Arylpyrroles.ACS Cent Sci2016
27654148Drug discovery and development in the era of Big Data.Future Med Chem2016
27678076A drug target slim: using gene ontology and gene ontology annotations to navigate protein-ligand target space in ChEMBL.J Biomed Semantics2016
26351271Improved large-scale prediction of growth inhibition patterns using the NCI60 cancer cell line panel.Bioinformatics2016
26501955Comprehensive characterization of the Published Kinase Inhibitor Set.Nat Biotechnol2016
26582922SureChEMBL: a large-scale, chemically annotated patent document database.Nucleic Acids Res2016
27654148Drug discovery and development in the era of Big Data.Future Med Chem2016
27800551Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos Arylpyrroles.ACS Cent Sci2016
27678076A drug target slim: using gene ontology and gene ontology annotations to navigate protein-ligand target space in ChEMBL.J Biomed Semantics2016
  • 1 - 50 of 212

Recommended Authors

Eloy Felix
European Bioinformatics Institute (EMBL-EBI)
Career Start Year 2019
Number of shared co-authors 6
Tunca Do??an
Hacettepe University
Career Start Year 2013
Number of shared co-authors 10
Rosalba Lepore
Basel University Hospital and University of Basel
Career Start Year 2011
Number of shared co-authors 7
Evan E Bolton
National Center for Biotechnology Information, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 8
Mark N Wass
University of Kent
Career Start Year 2007
Number of shared co-authors 11
Jacob D Durrant
University of Pittsburgh
Career Start Year 2006
Number of shared co-authors 1
Ola Spjuth
Department of Pharmaceutical Biosciences, Uppsala University
Career Start Year 2006
Number of shared co-authors 10
Avner Schlessinger
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 2003
Number of shared co-authors 10
Gerald H Lushington
Inc. 16 Dekalb Pike
Career Start Year 2002
Number of shared co-authors 0
Narcis Fernandez-Fuentes
Institute of Biological, Aberystwyth University
Career Start Year 2002
Number of shared co-authors 2
John J Irwin
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 2002
Number of shared co-authors 11
David Lagorce
INSERM
Career Start Year 1998
Number of shared co-authors 1
Patrick Aloy
Institucio Catalana de Recerca i Estudis Avancats (ICREA)
Career Start Year 1997
Number of shared co-authors 11
Vlado Dan????k
Broad Institute
Career Start Year 1997
Number of shared co-authors 3
Roberto Sanchez
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 3
Niklas Blomberg
Universitat Tubingen, Institut fur Arbeitsmedizin
Career Start Year 1996
Number of shared co-authors 13
David J Wild
Indiana University Bloomington
Career Start Year 1992
Number of shared co-authors 8
Ram Samudrala
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Career Start Year 1990
Number of shared co-authors 3
Robert Preissner
Institute for Physiology, Charite-University Medicine Berlin
Career Start Year 1990
Number of shared co-authors 3
Michael S Lajiness
Lilly Research Laboratories
Career Start Year 1989
Number of shared co-authors 2
Roland L Dunbrack
Fox Chase Cancer Center
Career Start Year 1989
Number of shared co-authors 3
Gerhard Klebe
Institut fur Pharmazeutische Chemie, Philipps-Universitat Marburg
Career Start Year 1988
Number of shared co-authors 2
Christopher W V Hogue
National University of Singapore
Career Start Year 1987
Number of shared co-authors 15
Alfonso Valencia
Josep Carreras Leukaemia Research Institute (IJC)
Career Start Year 1986
Number of shared co-authors 36
Russ B Altman
Stanford University
Career Start Year 1982
Number of shared co-authors 6
Ruben Abagyan
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Career Start Year 1981
Number of shared co-authors 5
Philip E Bourne
University of Virginia
Career Start Year 1980
Number of shared co-authors 11
Christine Humblet
Lilly Research Laboratories
Career Start Year 1977
Number of shared co-authors 3
Michael J E Sternberg
Imperial College London
Career Start Year 1976
Number of shared co-authors 17
Stephen H Bryant
National Center for Biotechnology Information
Career Start Year 1973
Number of shared co-authors 2

Collaborators

Anna Gaulton
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 24
Anne Hersey
Co-authored papers 20
George Papadatos
European Molecular Biology Laboratory - European Bioinformatics Institute
Co-authored papers 19
Tom L Blundell
Heartand Lung Research Institute, University of Cambridge
Co-authored papers 17
Mark S Johnson
Abo Akademi University
Co-authored papers 11
Bissan Al-Lazikani
The University of Texas MD Anderson Cancer Center
Co-authored papers 9
Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers 7
Tudor I Oprea
Expert Systems Inc.
Co-authored papers 6
Andrew L Hopkins
University of Dundee
Co-authored papers 5
Andrew R Leach
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 4
Bryan L Roth
UNC Chapel Hill School of Medicine
Co-authored papers 4
Juan P Casas
Co-authored papers 4
Aroon D Hingorani
Co-authored papers 4
Cristian G Bologa
University of New Mexico School of Medicine
Co-authored papers 4
Oleg Ursu
Co-authored papers 4
Anneli Karlsson
Co-authored papers 4
Anna Waller
Co-authored papers 3
Rajarshi Guha
Vertex Pharmaceuticals
Co-authored papers 3
Jeremy J Yang
Co-authored papers 3
Sameer Velankar
European Bioinformatics Institute
Co-authored papers 3
Herman W T van Vlijmen
Leiden Academic Centre for Drug Research (LACDR), Leiden University
Co-authored papers 3
Noel Southall
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 3
Ajit Jadhav
Co-authored papers 3
Jayme Holmes
Co-authored papers 3
Avi Ma'ayan
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Stephan C Sch??rer
Institute for Data Science and Computing, University of Miami
Co-authored papers 3
Dan Donnelly
University of Leeds
Co-authored papers 3
Dac-Trung Nguyen
Co-authored papers 3
S??ren Brunak
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Co-authored papers 3
Lluis Ballell
Global Health Pharma Unit
Co-authored papers 3
Release 1.2